Pharsight

1. Xdemvy patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8383659	TARSUS	Isoxazoline derivatives as pesticides	Jan, 2030 (6 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11690826	TARSUS	Methods for treating demodex blepharitis using lotilaner formulations	Dec, 2038 (15 years from now)
US11690827	TARSUS	Methods for treating ocular Demodex using lotilaner formulations	Dec, 2038 (15 years from now)
US11197847	TARSUS	Isoxazoline parasiticide formulations and methods for treating blepharitis	Dec, 2038 (15 years from now)
US10835517	TARSUS	Methods for treating ocular demodex using isoxazoline parasiticide formulations	Dec, 2038 (15 years from now)